Skip to main content
NewslettersWatchlist

Sangamo Therapeutics(SGMO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Sangamo Therapeutics

501 Canal Blvd
Richmond CA 94804 USA
P: 510-970-6000
F: 510-236-8951
http://www.sangamo.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States.

    Key Executives

    NameTitle
    Alexander Donald MacraeCEO/President/Director
    Prathyusha DuraibabuCFO/Chief Accounting Officer/Senior VP
    Scott B. WilloughbyGeneral Counsel/Secretary/Senior VP
    Nathalie Dubois-StringfellowOther Corporate Officer/Senior VP
    Amy PoolerOther Corporate Officer/Vice President

    More from The Globe

    Hoka-owner Deckers’ shares breach $1,000 mark for the first time
    Dr. Richard Ehrlich puts on his Hoka Stinson ATR trail running shoes in Caledon, Ontario, on Tuesday, December 23, 2014.
    Short sales on the TSX: What bearish investors are betting against
    Larry MacDonald
    Reminder: The Globe Investing Club wants your stock picks
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26.
    The close: Stocks rebound amid encouraging U.S. economic data
    Traders work on the floor of the New York Stock Exchange during morning trading on May 17.
    What every Canadian investor needs to know today
    Traders work on the floor of the New York Stock Exchange during morning trading on May 17, 2024 in New York City. Wall Street stocks opened little changed May 17 after pulling back from a record run where the Dow exceeded 40,000 points for the first time. Around 10 minutes into trading the Dow Jones Industrial Average was steady at 39,872.66. (Photo by ANGELA WEISS / AFP) (Photo by ANGELA WEISS/AFP via Getty Images)
    Bullish on Canadian National Railway Co.
    Monica Rizk
    Nvidia’s split of soaring stock could boost retail investor appeal, Dow chances
    A view of a Nvidia logo at their headquarters in Taipei, Taiwan May 31, 2023.
    The close: Stocks fall despite Nvidia boost as U.S. inflation concerns weigh; Dow sees worst drop since March 2023 on Boeing woes
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 16.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.